Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Navarat Chiengsorn"'
Autor:
Eugene Lam, Sriprapa Nateniyom, Sara Whitehead, Amornrat Anuwatnonthakate, Patama Monkongdee, Apiratee Kanphukiew, Jiraphan Inyaphong, Wanlaya Sitti, Navarat Chiengsorn, Saiyud Moolphate, Suporn Kavinum, Narin Suriyon, Pranom Limsomboon, Junya Danyutapolchai, Chalinthorn Sinthuwattanawibool, Laura Jean Podewils
Publikováno v:
Emerging Infectious Diseases, Vol 20, Iss 3, Pp 408-416 (2014)
In 2004, routine use of culture and drug-susceptibility testing (DST) was implemented for persons in 5 Thailand provinces with a diagnosis of tuberculosis (TB). To determine if DST results were being used to guide treatment, we conducted a retrospect
Externí odkaz:
https://doaj.org/article/5c63cd13d8b1475381666b98c85635fa
Autor:
Amornrat Anuwatnonthakate, Pranom Limsomboon, Sriprapa Nateniyom, Wanpen Wattanaamornkiat, Sittijate Komsakorn, Saiyud Moolphate, Navarat Chiengsorn, Samroui Kaewsa-Ard, Potjaman Sombat, Umaporn Siangphoe, Philip A Mock, Jay K Varma
Publikováno v:
PLoS ONE, Vol 3, Iss 8, p e3089 (2008)
BACKGROUND: The World Health Organization (WHO) recommends that tuberculosis (TB) patients receive directly observed therapy (DOT). Randomized controlled trials have not consistently shown that this practice improves TB treatment success rates. In Th
Externí odkaz:
https://doaj.org/article/9394b8cccb5147d2adbdbeb047349233
Autor:
Apiratee Kanphukiew, Laura Jean Podewils, Sara J. Whitehead, Narin Suriyon, Pranom Limsomboon, Suporn Kavinum, Navarat Chiengsorn, Sriprapa Nateniyom, Patama Monkongdee, Jiraphan Inyaphong, Chalinthorn Sinthuwattanawibool, Amornrat Anuwatnonthakate, Eugene Lam, Junya Danyutapolchai, Wanlaya Sitti, Saiyud Moolphate
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 20, Iss 3, Pp 408-416 (2014)
Emerging Infectious Diseases, Vol 20, Iss 3, Pp 408-416 (2014)
In 2004, routine use of culture and drug-susceptibility testing (DST) was implemented for persons in 5 Thailand provinces with a diagnosis of tuberculosis (TB). To determine if DST results were being used to guide treatment, we conducted a retrospect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::566daf304ec85d042f499c9c352db639
http://europepmc.org/articles/PMC3944855
http://europepmc.org/articles/PMC3944855
Autor:
Samroui Kaewsa-ard, Amornrat Anuwatnonthakate, Chalinthorn Sinthuwatanawibool, Waraya Amnuaiphon, Sadudee Rujiwongsakorn, Sitijate Komsakorn, Wanpen Wattanaamornkiet, Jay K. Varma, Prapa Nakara, Saiyud Moolphate, Prungsri Nuyongphak, Sriprapa Nateniyom, Navarat Chiengsorn
Publikováno v:
Tropical Medicine & International Health. 14:1338-1346
OBJECTIVES In countries with both TB and human immunodeficiency virus (HIV) epidemics, HIV is known to be the most powerful risk factor for death during tuberculosis (TB) treatment. Few recent studies have evaluated risk factors for death among HIV-u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3d4dfcb44da678f02f8f67293d60ce6
https://doi.org/10.1111/j.1365-3156.2009.02376.x
https://doi.org/10.1111/j.1365-3156.2009.02376.x